
O-Show 2022 coming to Sydney
Optical boutique event the O-Show will come to Hordern Pavilion, Moore Park, Sydney, 27-28 May 2022. Following the cancellation of the 2020 show due to Covid-19, this is a much-anticipated occasion,
4295 articles

Optical boutique event the O-Show will come to Hordern Pavilion, Moore Park, Sydney, 27-28 May 2022. Following the cancellation of the 2020 show due to Covid-19, this is a much-anticipated occasion,

A laboratory study measuring oxygen kinetics during corneal crosslinking (CXL) of porcine eyes showed that supplementary oxygen had the potential to substantially increase the procedure’s efficacy.

A modified technique for minor salivary gland transplantation (MSGT) as a treatment for severe dry eye disease (DED) led to long-term improvements in visual acuity, ocular surface environment and

Ocular Therapeutix said a phase-2 study of its OTX-CSI insert for the treatment of dry-eye disease (DED) missed its primary endpoint of increased tear production. The US-based clinical trial was

The following is a special Covid-19 update from the Optometrists and Dispensing Opticians Board (ODOB) 2 November 2021 From the ODOB: Alert Level Update As you would be aware, Government announced
Researchers at the Royal Melbourne Institute of Technology (RMIT) have demonstrated that an automated 10-second pupillary complexity test could detect open-angle glaucoma. Led by Professor Dinesh

Jean-François Rey, founder and CEO of French eyewear design company, Maison Jean-François Rey, has handed over control and executive responsibilities to the Franco-German trio of Walter Pirinoli, Dan Levi and Ralf Kmoch.

Ciclosporin (Ikervis) has been listed on the Pharmaceutical Benefits Scheme (PBS) in Australia, saving around 7,500 severe keratitis patients with dry eye disease (DED) an estimated A$900 each per year, said Greg Hunt, Minister for Health and Aged Care.

A retrospective cohort study in the US has shown that patients with non-infectious uveitis (NIU) are more likely to contract Covid-19 and experience severe outcomes. However, this association was due to the demographics, comorbidities and medications of patients with NIU, rather than to NIU alone, r

An anti-cataract intravitreal implant has completed non-clinical testing, with an Australian phase 1/2 clinical study now underway.

The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has launched ‘The Tick’, an endorsement that an event has achieved 35% female representation.

The Optometrists and Dispensing Opticians Board (ODOB) is reviewing its cultural competence standards and has completed a consultation to secure member feedback. Chair Jayesh Chouhan said the cultural standards were last reviewed in 2018, so were due for a review this year.